Skip to main content

Table 5 Correlation between survival and combined marker expression

From: Clinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancer

 

No.

Cumulative survival (%)

Median ± SE

95% CI

p. value

Nm23 (-)& p53 (+)

9

11

6 ± 1.49

3.08 – 8.92

 

Other combinations

50

57

43 ± -

-

0.0004

Nm23 (-)& EGFR (+)

18

28

10 ± 3.18

3.76 – 16.24

 

Other combinations

41

60

43 ± -

-

0.029

EGFR (+)& p53 (+)

11

18

6 ± 3.85

0 – 13.55

 

Other combinations

48

58

43 ± -

-

0.0002

Nm23 (-), p53 (+), EGFR (+)

6

15

5.8 ± 3.85

0.1–13.55

0.0001

Other combinations

53

59

43 ± -

-

 

Nm23 (-), p53 (+), EGFR (+)& b (-)

7

9

4 ± 5.62

1.45 – 20.21

<0.0001

Other combinations

52

58

50 ± -

-

Â